This drug delivery system is efficient because of its ability to target cancer cells by recognition of CD44 receptors, inhibition of overexpressed cyclooxygenase-2 in cancer cells, improvement of cellular uptake, and improved biodistribution [113]. Here, PTGS2 is linked to cancer.